Skip to Content
PharmaceuticalsPharmaceuticals
  • Correction
  • Open Access

1 April 2024

Correction: Liu et al. The Discovery of Novel Agents against Staphylococcus aureus by Targeting Sortase A: A Combination of Virtual Screening and Experimental Validation. Pharmaceuticals 2024, 17, 58

,
,
,
,
,
,
,
and
1
College of Bioscience and Biotechnology, Yangzhou University, Yangzhou 225009, China
2
College of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou 225009, China
3
Department of the Heart and Great Vessels, Affiliated Hospital of Yangzhou University, Yangzhou 225009, China
*
Authors to whom correspondence should be addressed.
This article belongs to the Section Biopharmaceuticals

Error in Table and Figure Description

In the original publication [1], there were mistakes in Table 1 as published. Firstly, the molecular structures of screened compound ID 2 (Naldemedine) and compound ID 4 (Norgestrel) were described incorrectly. Secondly, compound ID 8 (Doxycycline) was inconsistent with the structure in Figure S8. The correct name of compound 8 is Simeprevir. The corrected Table 1, along with corresponding corrections in the Table S1 and Figure S8 descriptions, are provided below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Table 1. The molecular docking results indicate that the top 12 drugs have binding energies below −9.0 kcal/mol. The positive and negative controls are depicted in the final two lines. The occupied sites correspond to the binding sites of LPXTG, as shown in Figure 1c.
Table S1. Binding sites of 12 screened drugs and two controls. Residues marked in red are the functional sites of SrtA, as indicated in Figure 1c.
Figure S8. Analysis of the binding pose of Simeprevir with SrtA. (a) The structure of the complex. Three-dimensional (b) and two-dimensional (c) interaction diagrams of the binding pose of Simeprevir with SrtA.

Reference

  1. Liu, K.; Tong, J.; Liu, X.; Liang, D.; Ren, F.; Jiang, N.; Hao, Z.; Li, S.; Wang, Q. The Discovery of Novel Agents against Staphylococcus aureus by Targeting Sortase A: A Combination of Virtual Screening and Experimental Validation. Pharmaceuticals 2024, 17, 58. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.